Call Options Transactions Made in Q3 2023 in Biocryst Pharmaceuticals Inc (BCRX)
This table provides information about the institutional ownership of Biocryst Pharmaceuticals Inc (BCRX) during Q3 2023. The information is specifically focused on institutions that hold call options of BIOCRYST PHARMACEUTICALS INC.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 14, 2023
Q3 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
CALL |
198K+ 32.53% |
$1.33M - $1.57M
|
808K
$6.14M
|
|
Nov 15, 2023
Q3 2023
|
Gts Securities LLC
New York, NY |
BUY
|
CALL |
111KNew |
$746K - $881K
|
111K
$845K
|
|
Nov 15, 2023
Q3 2023
|
Wolverine Trading, LLC
Chicago, IL |
BUY
|
CALL |
74.7K+ 83.0% |
$501K - $592K
|
165K
$1.25M
|
|
Nov 14, 2023
Q3 2023
|
Caption Management, LLC
Oklahoma City, OK |
BUY
|
CALL |
62.5KNew |
$419K - $495K
|
62.5K
$475K
|
|
Nov 14, 2023
Q3 2023
|
Walleye Capital LLC
Plymouth, MN |
BUY
|
CALL |
54.5K+ 349.36% |
$366K - $432K
|
70.1K
$533K
|
|
Nov 14, 2023
Q3 2023
|
Walleye Trading LLC
Plymouth, MN |
BUY
|
CALL |
35K+ 284.55% |
$235K - $277K
|
47.3K
$359K
|
|
Nov 14, 2023
Q3 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
CALL |
-55.8K- 9.25% |
$374K - $442K
|
547K
$4.16M
|